Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Neoplasms | Phase 1 | ClinicalTrials |
| Carcinoma, Small Cell; Lung Neoplasms; Small Cell Lung Carcinoma | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung; Lung Neoplasms | Phase 2 | ClinicalTrials |
| Papilloma; Papillomavirus Infections; Respiratory Tract Infections | Phase 2 | ClinicalTrials |
| Biliary Tract Neoplasms; Cholangiocarcinoma; Gallbladder Neoplasms | Phase 2/Phase 3 | ClinicalTrials |
| Biliary Tract Neoplasms; Cholangiocarcinoma; Gallbladder Neoplasms | Phase 2 | ClinicalTrials |
| Neoplasms; Prostatic Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Adenocarcinoma; Pancreatic Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Neoplasms | Phase 1 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung; Lung Neoplasms | Phase 2 | ClinicalTrials |
| Anus Neoplasms; Neoplasms; Oropharyngeal Neoplasms; Papilloma; Penile Neoplasms | Phase 2 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung; Lung Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
CONTENTS